 |
multi-epitope folate receptor alpha peptide vaccine with GM-CSF adjuvant (TPIV200) |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-12-07 00:00:00 |
| Sponsor | Tapimmune, Inc.;50 North Laura Street;Jacksonville, Florida, 32202 |
